Assets Under Advice | Fees for 3years | |
35 lacs to 99 lacs | 3% + GST | |
1 Cr to 2.99 Cr | 2.5% + GST | |
3 Cr to 9.99 Cr | 2% + GST | |
10 Cr + | Customised Fees | |
GST @ 18% | ||
|
Please contact us for details | ||
|
Nippon India Nifty Pharma ETF has delivered CAGR and average rolling returns as follows :
1 Year | 3 Year | 5 Year | 9 Year | |
CAGR(%) | 11.7 | 16.49 | N/A | N/A |
Average Rolling Returns(%) | 23.48 | 17.47 | N/A | N/A |
The Current NAV of Nippon India Nifty Pharma ETF is ₹20.39.
It is better to invest in a fund with a longer track record as Nippon India Nifty Pharma ETF cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 50 returns, as Funds portfolio is significantly different.
Nippon India Nifty Pharma ETF fund’s expense ratio is 0.21%
The process for redemption is
The AUM of Nippon India Nifty Pharma ETF is currently ₹856 Crores.
The Top three stocks are Sun Pharma Inds., Cipla and Divis Lab and account for 45% of its portfolio. Top 5 and 10 stocks of fund account for 61% and 80% of fund’s portfolio respectively.
Top three sectors of Nippon India Nifty Pharma ETF fund are Healthcare, Miscellaneous and accounting for 100% of the total portfolio.
Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a ETFs - Index it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of Nippon India Nifty Pharma ETF Fund is ETFs - Index.
Jitendra Tolani manages the Nippon India Nifty Pharma ETF Fund.
Nippon India Nifty Pharma ETF current PE ratio is 40.49 and PB ratio is 6.09
The asset allocation of Nippon India Nifty Pharma ETF is Stocks : 99.97%, Debt : 0.04% and Gold : 0%
The minimum SIP amount for Nippon India Nifty Pharma ETF is N/A and minimum lumpsum is ₹1000.00
The exit load for Nippon India Nifty Pharma ETF is N/A